Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

San Diego Convention Center

Jun 15, 2014 8:30 AM - Jun 19, 2014 12:45 PM

111 W Harbor Drive, , San Diego, CA 92101 , USA

DIA 2014 50th Annual Meeting "Celebrate the Past - Invent the Future"

Pediatric Trials: Improvements through Bayesian Methods, Adaptive Designs, and Modeling/Simulation

Session Chair(s)

Gesine  Bejeuhr, PharmD

Gesine Bejeuhr, PharmD

Pediatric Regulatory Leader

Bayer AG, Germany

This session provides practical examples of how Bayesian methods, adaptive designs and other statistical methods including modeling and simulation could contribute to pediatric trials and lead to better design and fewer children to be exposed. This session will stimulate a dialogue between technical experts in statistics/adaptive design and those who are involved in clinical trials, particularly examining pertinent questions: (1) What are the messages from statistics/adaptive design to be understood by those who are involved in pediatric development and then by those who are asked to consent to participate in clinical trials?, (2) What are the messages for key decision makers in pharmaceutical companies to agree to adaptive design/Bayesian or any other method?, and (3) What do authorities need?

This session has been developed by the DIA Pediatric Community and the Bayesian and Adaptive Design Scientific Working Groups.

Learning Objective : Describe results of the collaboration between the DIA Pediatric Community and Bayesian and Adaptive Design Scientific Working Groups; Examine potential applications of Bayesian methods and adaptive designs to improve pediatric medical product development; Identify opportunities to collaborate on application of novel approaches in pediatric designs via open discussion and case examples; Provide information to prepare the right messages to patients, investigators, and industry decision-makers.

Speaker(s)

Scott  Berry, PhD

Bayesian Statistics and Adaptive Design

Scott Berry, PhD

Berry Consultants LLC, United States

President and Senior Statistical Scientist

Freda  Cooner, PhD

Pediatric Studies and Bayesian Statistics: Challenges and Opportunities

Freda Cooner, PhD

Eli Lilly and Company, United States

Senior Director - Statistics

Brenda  Cirincione, PhD, MS

Pharmaceutical Company Perspective

Brenda Cirincione, PhD, MS

Vertex, United States

Vice President, Clinical and Quantitative Pharmacology

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.